APTV vs KYTX · P/E 41, rev $19.71B vs $488.8M cap
Aptiv PLC (APTV) versus Kyverna Therapeutics, Inc. Common Stock (KYTX) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Kyverna Therapeutics, Inc. Common Stock (KYTX) is a biotechnology company listed on NASDAQ.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
KYTX does not have a complete income-statement cache yet.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. KYTX currently screens at market cap $488.8M.
Not investment advice. Open the APTV and KYTX stock pages for the full models.
Not investment advice.